Search This Blog

Labels

T 1030/19 - Plants filed before 1 July 2017


In the present case,  the examining division held, in its decision dated 28 November 2018, that the subject-matter of the set of claims of the main request and of auxiliary requests 1 to 4 fell under the exclusions from patentability as defined by Rule 28(2) EPC and that, consequently, the application did not meet the requirements of Article 53(b) EPC. In the grounds of appeal of 28 March 2019, the applicant referred to T 1063/18 which decided that Rule 28(2) is in conflict with Art.53(b) as interpreted by the Enlarged Board in G 2/12 and G 2/13 and that the refusal in that case based on Rule 28(2) should be set aside. While the current appeal was pending, the President referred questions to the Enlarged Board. The Board waited until G 3/19 was decided before ruling on this case.


BREAKING NEWS: G 3/19 - Plants and animals exclusively obtained by essentially biological processes are not patentable, but no retroactive effect

Today, the EPO issued a Press Communiqué concerning opinion G 3/19 of the Enlarged Board of Appeal. (link)

The Press Communiqué is cited in full below (with emphasis added).

The full decision can be found here (G 3/19). Further references are given at the end of the Press Communiqué.

The headnote of the decision reads:

Taking into account developments after decisions G 2/12 and G 2/13 of the Enlarged Board of Appeal, the exception to patentability of essentially biological processes for the production of plants or animals in Article 53(b) EPC has a negative effect on the allowability of product claims and product-by-process claims directed to plants, plant material or animals, if the claimed product is exclusively obtained by means of an essentially biological process or if the claimed process features define an essentially biological process. This negative effect does not apply to European patents granted before 1 July 2017 and European patent applications which were filed before that date and are still pending.

----
[start of citation of Press Communiqué]

Press Communiqué of 14 May 2020 concerning opinion G 3/19 of the Enlarged Board of Appeal


The Enlarged Board of Appeal of the European Patent Office issued opinion G 3/19 (Pepper) today and concluded that plants and animals exclusively obtained by essentially biological processes are not patentable.
The Enlarged Board of Appeal of the European Patent Office adopted a dynamic interpretation of the exception to patentability under Article 53(b) of the European Patent Convention (EPC) and held that the non-patentability of essentially biological processes for the production of plants or animals also extends to plant or animal products that are exclusively obtained by means of an essentially biological process.

Background

The Enlarged Board of Appeal is the highest judicial authority under the EPC, which provides for an autonomous legal system that is separate from the European Union. The Enlarged Board's main task is to ensure the uniform application of the EPC.
Under Article 53(b) EPC, European patents shall not be granted in respect of plant or animal varieties or essentially biological processes for the production of plants or animals. Rule 28(2) EPC provides that under Article 53(b) EPC, European patents shall not be granted in respect of plants or animals exclusively obtained by means of an essentially biological process. Rule 28(2) EPC was introduced by decision of the Administrative Council of the European Patent Organisation and came into force on 1 July 2017.
In 2015, the Enlarged Board had concluded in its decisions G 2/12 and G 2/13 within the then applicable legal framework, i.e. before the introduction of Rule 28(2) EPC, that the non‑patentability of essentially biological processes for the production of plants or animals under Article 53(b) EPC did not extend to products that are exclusively obtained by means of an essentially biological process.
In 2018, a Technical Board of Appeal held in decision T 1063/18 that new Rule 28(2) EPC had no impact on the interpretation of Article 53(b) EPC, and followed the Enlarged Board's earlier decisions G 2/12 and G 2/13.
In 2019, the President of the European Patent Office referred a point of law to the Enlarged Board of Appeal under Article 112(1)(b) EPC concerning the interpretation of Article 53(b) EPC in view of legal and other developments occurring after decisions G 2/12 and G 2/13, and in particular in view of new Rule 28(2) EPC.

Key considerations

In its opinion issued today, the Enlarged Board of Appeal held the referral by the President of the European Patent Office to be admissible within the terms of a re‑phrased question. On the merits of the referral, the Enlarged Board endorsed its earlier findings on the scope of Article 53(b) EPC, which were based on the classical (i.e. the grammatical, systematic, teleological and historical) methods of interpretation. However, the Enlarged Board found that a particular interpretation which has been given to a legal provision can never be taken as carved in stone, because the meaning of the provision may change or evolve over time. This meant that decisions G 2/12 and G 2/13 did not settle the meaning of Article 53(b) EPC once and for all.
Taking account of the Administrative Council's decision to introduce Rule 28(2) EPC, the preparatory work on this provision and the circumstances of its adoption, as well as legislative developments in the EPC contracting states, the Enlarged Board concluded that new Rule 28(2) EPC allowed and indeed called for a dynamic interpretation of Article 53(b) EPC.
In adopting this dynamic interpretation, the Enlarged Board abandoned its earlier interpretation of Article 53(b) EPC in decisions G 2/12 and G 2/13. It held that, after the introduction of new Rule 28(2) EPC, Article 53(b) EPC was to be interpreted to exclude from patentability plants, plant material or animals, if the claimed product is exclusively obtained by means of an essentially biological process or if the claimed process features define an essentially biological process.
In order to ensure legal certainty and to protect the legitimate interests of patent proprietors and applicants, the Enlarged Board ruled that the new interpretation of Article 53(b) EPC given in G 3/19 had no retroactive effect on European patents containing such claims which were granted before 1 July 2017, or on pending European patent applications seeking protection for such claims which were filed before that date.

Contact

Nikolaus Obrovski
Spokesperson of the Boards of Appeal of the European Patent Office
BOA-PRESS@epo.org
This press release is a non-binding document for media use.

Further information

06.07.1998
EU Directive 98/44/EC of the European Parliament and of the Council on the legal protection of biotechnological inventions;
16.06.1999
Decision CA/D 10/99 of the Administrative Council, insertion of new Chapter VI "Biotechnological inventions" in Implementing Regulations to the EPC;
09.12.2010
G 2/07 (Broccoli I), Decision of the Enlarged Board of Appeal;
G 1/08 (Tomatoes I), Decision of the Enlarged Board of Appeal;
25.03. 2015
G 2/12 (Tomatoes II), Decision of the Enlarged Board of Appeal;
G 2/13 (Broccoli II), Decision of the Enlarged Board of Appeal;
01.07.2017
Rule 28(2) EPC (entry into force), see Decision CA/D 6/17 of the Administrative Council;
05.12.2018
T 1063/18, Decision of Technical Board of Appeal 3.3.04;
decision text (not published in OJ EPO)
05.04.2019
Referral of a point of law by the President of the EPO;
14.05.2020
G 3/19 (Pepper), Opinion of the Enlarged Board of Appeal;
opinion text (not yet published in OJ EPO)
Amicus curiae briefs
[end of citation of Press Communiqué]
----

G 3/19 - Patentability of plants exclusively obtained by essentially biological processes: the referral


The full text of the referral by the President to the Enlarged Board of Appeal relating to the patentability of plants exclusively obtained by essentially biological processes is available online. Also see our earlier posts (w.r.t annoucemcentearlier annoucement T 1063/18 and first news message)). The accompanying letter is dated 4.04.2019 and was received in the BoA Office on 08.04.2019.


Under Article 112(1)(b) EPC the President of the European Patent Office refers the following points of law to the Enlarged Board of Appeal:

1. Having regard to Article 164(2) EPC, can the meaning and scope of Article 53 EPC be clarified in the Implementing Regulations to the EPC without this clarification being a priori limited by the interpretation of said Article given in an earlier decision of the Boards of Appeal or the Enlarged Board of Appeal?

2. If the answer to question 1 is yes, is the exclusion from patentability of plants and animals exclusively obtained by means of an essentially biological process pursuant
to Rule 28(2) EPC in conformity with Article 53(b) EPC which neither explicitly excludes nor explicitly allows said subject-matter?

News: President referred questions to the Enlarged Board on patentability of plants exclusively obtained by essentially biological processes


Following his earlier annoucement, the President has submitted questions too the Enlarged Board of Appeal which relate to the patentability of plants exclusively obtained by essentially biological processes and to decision T 1063/18 (also here). According to a news meesage from the EPO posted last Friday, the President of the EPO seeks the Enlarged Board of Appeal to clarify the applicable legal framework.
The full text of the referral is not yet available. It will be interesting to see which clarifiation the Preseident seems to be required as one may argue that T 1063/18 has already given the answer, as that decision analyzed whether conclusion from G 2/12 needed any adaptations after the introduction of Rule 28(2) EPC subsequent to a notice from the EU Commission (no). Also, the news message below does not mention any conflicting decision, which is needed for the referral to be admissable under article Art.112(1)(b) EPC. (However, also with an inadmissible referral, the Enlarged Board may give a clarification as it did in the software decision G 3/08). So, the full text will be highly interesting, we will keep you posted!

News: President will ask Enlarged Board for opinion on patentability of plants exclusively obtained by essentially biological processes


In the latest meeting of the Administrative Council, the President expressed his view that referral of the case to the Enlarged Board of Appeal is justified and necessary, in view of the legal uncertainty caused by decision T 1063/18 (also here). 

T 1063/18 - The full decision: why Rule 28(2) is in conflict with Art.53(b) EPC and why no referral was necessary


On 7 December, the Board of Appeal posted a communication on their website wherein the decision in case T 1063/18 on the patentability of plants was summarized (see here). Yesterday, the complete written decision was issued and became available in the register. In the Decision, the Board does not only motivate in detail why Rule 28(2) EPC as it was amended is in conflict with Art. 53(b) EPC as interpreted by the Enlarged Board in G 2/12 and G 2/13, as well as why the Adm Council was not competent to adopt this Rule, as well as why no further referral was needed - the Board also explained why they consider the opinion of the Enlarged Board to be unchanged also after the Commission Notice after the amendment to Rule 28(2) EPC. Not all arguments submitted by the parties and third parties were addressed in view of the intermediate conclusions taken - so, unfortunately, whether there is a difference as to what the scope of the exclusion of "essentially biologial processes" or not, was not discussed by the Boards (one submission argued that the Commission uses a narrow exclusion (strictly 100% biological, without any techncal step) whereas the Enlarged Board uses a broad exclusion (crossing whole genomes, irrespective of whether further technical steps are also excluded): if Rule 28(2) EPC would have been maintained, that could have meant that it excluded more than was intended.
This will probably not be the last legal development on patentability of "plants exclusively obtained by means of an essentially biological process" via Art. 53(b) EPC or otherwise... 


Hot News: T 1063/18 - Rule 28(2) EPC in conflict with Art.53(b) as interpreted by the EBoA in G 2/12 and G 2/13.


Hot News: Communication from the BoAs (link):

Decision in case T 1063/18 on the patentability of plants

7 December 2018

Case T 1063/18 concerns the appeal by the applicant against the decision of the examining division to refuse European patent application no. 12 756 468.0 (publication no. EP 2 753 168) for the sole reason that the claimed subject-matter falls within the exception to patentability according to Article 53(b) and Rule 28(2) EPC (here: plants exclusively obtained by means of an essentially biological process).

At the oral proceedings, which took place on 5 December 2018, Technical Board of Appeal  3304, in an enlarged composition consisting of three technically and two legally qualified members, held that Rule 28(2) EPC (see OJ 2017, A56) is in conflict with Article 53(b) EPC as interpreted by the Enlarged Board of Appeal in decisions G 2/12 and G 2/13. The Board referred to Article 164(2) EPC, according to which the provisions of the Convention prevail in case of conflict with the Implementing Regulations, and decided to set the decision under appeal aside and to remit the case to the examining division for further prosecution.

The written decision containing the board's full reasons is expected to be issued early next year.

We will post another blog as soon as the written decision is available The file wrapper can be found here. Photo "Farmer's Market Summer Colors" by Luxbao obtained via Flickr under Public Domain Mark 1.0

------------------------------
Update 19-12-2018: Minutes from Oral proceedings before the Board available

The minutes from the oral Proceedings of 5 December 2018 are available in the EP Register (here) and are cited in full below (emphasize aded by the blog editor).

Appeal number T1063/18-3.3.04

Application No.: 12756468.0
Applicant: Syngenta Participations AG


Minutes of the oral proceedings
of 5 December 2018

Composition of the Board:

Chair: G. Alt
Members: R. Morawetz
                 P. de Heij
                 A. Chakravarty
                 L. Bühler

Start of oral proceedings: 09:30 hours
End of oral proceedings:  13:00 hours

 Present on behalf of the appellant:

Mr M. A. Kock, authorised by an authorisation dated 19 October 2018, and Mr N. Amelot, professional representatives, both identified by EPO-identity card.

The chair declared the oral proceedings open. She noted that the board had been enlarged pursuant to Article 21(3)(b) EPC and Article 9 RPBA. She then summarised the relevant facts as they appeared from the file. The appellant confirmed that they had received all third parties observations on file.

The chair stated that the board had taken note of the third parties observations. The chair also stated that the board intended to decide whether the decision to refuse the application was correct.

The chair ascertained the appellant ’s opening requests which the board understood to be as follows.

The appellant requested:

- as the main request: That the decision under appeal be set aside and, should the board remain of the opinion that the grounds raised in the communication of the board prevented the application from being granted, the case be remitted to the examining division for further prosecution on the basis of the set of claims filed on 7 August 2015;

- as auxiliary request 1: Should the board not be in a position to take a decision on the validity and/or scope of Rule 28(2) EPC according to the main request or see points of law of fundamental importance, questions be referred to the Enlarged Board of Appeal as suggested in the statement of grounds of appeal dated 5 April 2018, including a question to clarify the apparent contradiction between the definitions of essentially biological processes under G 2/07 and under Rule 27(c) EPC and the Biotechnology Directive 98/44, as further construed by the Commission Notice;

- as auxiliary request 2: Should the board be minded to dismiss the appeal without deciding on the appellant's main request to set aside the decision of the examining division, the following question be submitted to the Enlarged Board of Appeal: "Is a Board of Appeal entitled to reject an appeal on grounds not related to the appeal without first deciding on the Appellant's Main Request to set aside the decision of the Examining Division?";

- as auxiliary request 3: Should the board intend to reject the request to remit the case to the examining division for further prosecution on the basis of the set of claims filed on 7 August 2015, a patent be granted on the basis of an amended set of claims filed as auxiliary request 4 with the letter dated 26 October 2018.

The chair summarised the appellant’s different lines of argument presented in writing. She noted that one of these lines was that Rule 28(2) EPC was in conflict with Article 53(b) EPC, as interpreted by the Enlarged Board of Appeal in decisions G 2/12 and G 2 /13, and that therefore Article 164(2) EPC applied. She invited the appellant to first present comments on this line of argument.

The appellant presented their arguments on the matter and stated that they agreed with the observations of the third party Konig, which the board should take into consideration, and had nothing to add to the comments provided by Konig on the observations of the third party ESA (European Seed Association). [Note: both third parties made multiple submissions - see EP Register]

After deliberation, the chair announced that the board was of the opinion that Rule 28(2) EPC was in conflict with Article 53(b) EPC, as interpreted by the Enlarged Board of Appeal in decisions G 2/12 and G 2/13, and that in accordance with Article 164(2) EPC the provisions of the Convention prevailed.

Next, the appellant presented their arguments in support of the request for remittal to the examining division. These were, inter alia, that the objections of lack of inventive step and lack of clarity had been raised by the board and that they had the right to have these objections considered by two instances.

After another break for deliberation by the board, the chair stated that the board would not order the remittal of the case at the present stage of the oral proceedings, but would reconsider the request after the appellant had been heard on the issue of inventive step of the subject-matter of claim 1 of the main request. There was no loss of instance for this issue because the examining division had provided an opinion on inventive step.

As regards document D1 and the San Luis Ancho pepper disclosed therein, the appellant submitted that it was not known whether the features in claim 1 defining the extreme dark green colour of the fruit at immature harvestable state, i.e. the chlorophyll A and chlorophyll B, lutein and violaxanthin  content, were inherent features of the San Luis Ancho pepper. The dark green colour of the pepper as not necessarily linked to these features. An analysis of the chlorophyll and carotenoid content of the San Luis Ancho pepper could provide the relevant information, however, the appellant's experts had not had sufficient time to carry out such an analysis.

The proceedings were again interrupted for deliberation of the board. After resumption, the chair announced that the board had reconsidered the request for remittal and had decided to remit the case to the examining division for further prosecution. This would allow the appellant to carry out an  analysis of the San Luis Ancho pepper to support their arguments on inventive step.

The chair asked the appellant to state their final requests. These were the same as their opening requests.

The chair asked the appellant if they had any further comments or observations. They had none.

The chair then closed the debate and announced the following decision of the board:

1. The decision under appeal is set aside.

2. The case is remitted to the examining division for further prosecution on the basis of the set of claims of the main request, as filed on 7 August 2015.

The chair then closed the oral proceedings.

The Minute Writer: P. de Heij
The Chair: G. Alt